BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23553743)

  • 1. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events.
    Zeidan AM; Streiff MB; Lau BD; Ahmed SR; Kraus PS; Hobson DB; Carolan H; Lambrianidi C; Horn PB; Shermock KM; Tinoco G; Siddiqui S; Haut ER
    Am J Hematol; 2013 Jul; 88(7):545-9. PubMed ID: 23553743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
    Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
    Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic outcomes with appropriate or partial prophylaxis.
    Amin AN; Lin J; Johnson BH; Schulman KL
    Thromb Res; 2010 Jun; 125(6):513-7. PubMed ID: 19931121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based venous thromboembolism prophylaxis is associated with a six-fold decrease in numbers of symptomatic venous thromboembolisms in rehabilitation inpatients.
    Mayer RS; Streiff MB; Hobson DB; Halpert DE; Berenholtz SM
    PM R; 2011 Dec; 3(12):1111-1115.e1. PubMed ID: 22192320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism.
    Yun R; Sciubba DM; Lewin JJ; Streiff MB; Haut ER; Lau BD; Shermock KM; Kraus PS; Popoola VO; Dalpoas SE
    World Neurosurg; 2020 Feb; 134():e664-e671. PubMed ID: 31698120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a venous thromboembolism prophylaxis program for hospitalized patients.
    Cardoso LF; Krokoscz DV; de Paiva EF; Furtado IS; Mattar J; de Souza E Sá MM; de Lira AC
    Vasc Health Risk Manag; 2016; 12():491-496. PubMed ID: 28003757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a mandated venous thromboembolism clinical order set improves venous thromboembolism core measures.
    Khoury L; Dangodara AA; Lee JA; Lovejoy M; Amin AN
    Hosp Pract (1995); 2014 Dec; 42(5):89-99. PubMed ID: 25485921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Postoperative Venous Thromboembolism in Thoracic Surgical Patients: Implementation and Evaluation of a Caprini Risk Assessment Protocol.
    Hachey KJ; Sterbling H; Choi DS; Pinjic E; Hewes PD; Munoz J; McAneny D; Tripodis Y; Fernando HC; Litle VR
    J Am Coll Surg; 2016 Jun; 222(6):1019-27. PubMed ID: 26775163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the National Inpatient Medication Chart improves venous thromboembolism prophylaxis rates in high-risk medical patients.
    Yates M; Reddy M; Machumpurath B; Phelps G; Hampson SA
    Intern Med J; 2014 Feb; 44(2):190-4. PubMed ID: 24528815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliminating Health Care Disparities With Mandatory Clinical Decision Support: The Venous Thromboembolism (VTE) Example.
    Lau BD; Haider AH; Streiff MB; Lehmann CU; Kraus PS; Hobson DB; Kraenzlin FS; Zeidan AM; Pronovost PJ; Haut ER
    Med Care; 2015 Jan; 53(1):18-24. PubMed ID: 25373403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
    Yang LS; Alukaidey S; Croucher K; Dowling D
    Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
    Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
    Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.
    Rocher WD; Page T; Rocher M; Nel D
    S Afr Med J; 2019 Feb; 109(3):178-181. PubMed ID: 30834875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Johns Hopkins Venous Thromboembolism Collaborative: Multidisciplinary team approach to achieve perfect prophylaxis.
    Streiff MB; Lau BD; Hobson DB; Kraus PS; Shermock KM; Shaffer DL; Popoola VO; Aboagye JK; Farrow NA; Horn PJ; Shihab HM; Pronovost PJ; Haut ER
    J Hosp Med; 2016 Dec; 11 Suppl 2():S8-S14. PubMed ID: 27925423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.
    Goldin M; Cohen J; Makhnevich A; Mulvany C; Akerman M; Sinvani L
    J Thromb Thrombolysis; 2018 Apr; 45(3):369-376. PubMed ID: 29330739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.
    Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Zayaruzny M; Emery L; Anderson FA;
    Lancet; 2008 Feb; 371(9610):387-94. PubMed ID: 18242412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.